Top

Journal of Interventional Cardiac Electrophysiology

Published in:

01-03-2014

Single-center experience of a quadripolar pacing lead for cardiac resynchronization therapy

Authors: Antonello Vado, Endrj Menardi, Guido Rossetti, Gianpaolo Ballari, Mauro Feola, Marco Bobbio

Published in: Journal of Interventional Cardiac Electrophysiology | Issue 2/2014

Abstract

AIM

Recent studies have shown that a quadripolar left ventricular (LV) lead can result in low rates of dislocation and phrenic nerve stimulation (PNS) acutely and on medium-term follow-up in cardiac resynchronization therapy (CRT). We evaluated the outcomes of CRT patients in whom a quadripolar LV lead was implanted in our institution.

Methods

We studied 45 consecutive heart failure patients (75 % men; age, 70.3 ± 9.0 years) following successful implantation of a quadripolar LV lead. Demographic and clinical data were collected preoperatively, and patients were followed up for 18.9 months.

Results

The implantation success rate was 100 %. Mean overall duration was 100.1 ± 34.6 min, and X-ray exposure time was 13.20 ± 13.5 min. The most distal effective pacing site was used as the final pacing configuration in all patients. Acute dislodgment requiring reoperation occurred before discharge in three cases (6.6 %). Six patients (13 %) suffered PNS during follow-up; we solved this problem by changing the stimulation vector. Three months after implantation, a mean of six out of ten effective sites (threshold <2.5 V at 1.5 ms, no PNS) per patient was recorded.

Conclusions

Over the relatively long term, the quadripolar LV lead was associated with excellent pacing thresholds and low rates of dislocation and PNS.

Bristow, M. R., Saxon, L. A., Boehmer, J., et al. (2004). Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New England Journal of Medicine, 350, 2140–2150.PubMedCrossRef

Cleland, J. G., Daubert, J. C., Erdmann, E., et al. (2005). Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352, 1539–1549.PubMedCrossRef

Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., et al. (2008). ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation, 117, e350–e408.PubMed

Shetty, A. K., Duckett, S. G., Bostock, J., et al. (2011). Initial single-center experience of a quadripolar pacing lead for cardiac resynchronization therapy. Pacing and Clinical Electrophysiology, 34, 484–489.PubMedCrossRef

Sperzel, J., Danschel, W., Gutleben, K. J., et al. (2012). First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead. Europace, 14, 365–372.PubMedCrossRef

Forleo, G. B., Della Rocca, D. G., Papavasileiou, L. P., Molfetta, A. D., Santini, L., & Romeo, F. (2011). Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcomes. Heart Rhythm, 8, 31–37.PubMedCrossRef

Burger, H., Schwarz, T., Ehrlich, W., Sperzel, J., Kloevekorn, W. P., & Ziegelhoeffer, T. (2011). New generation of transvenous left ventricular leads—first experience with implantation of multipolar left ventricular leads. Experimental and Clinical Cardiology, 16, 23–26.PubMedCentralPubMed

Della Rocca, D. G., Forleo, G. B., Santini, L., & Romeo, F. (2012). Without a quadripolar left ventricular lead you don't succeed: a challenging case of phrenic nerve stimulation. International Journal of Cardiology, 155, e37–e38.PubMedCrossRef

Mehta, P. A., Shetty, A. K., Squirrel, M., Bostock, & Rinaldi, C. A. (2012). Elimination of phrenic nerve stimulation occurring during CRT: follow-up in patients implanted with a novel quadripolar pacing lead. Journal of Interventional Cardiac Electrophysiology, 33, 43–49.PubMedCrossRef

10.

Forleo, G. B., Mantica, M., Di Biase, L., et al. (2012). Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study. Heart Rhythm, 9, 1822–1828.PubMedCrossRef

11.

Butter, C., Auricchio, A., Stellbrink, C., et al. (2001). Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation, 104, 3026–3029.PubMedCrossRef

12.

Gurevitz, O., Nof, E., Carasso, S., et al. (2005). Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation. Pacing and Clinical Electrophysiology, 28, 1255–1259.PubMedCrossRef

13.

Biffi, M., Schau, T., Moeller, V., et al. (2009). Phrenic stimulation: a challenge for cardiac resynchronization therapy. Circulation. Arrhythmia and Electrophysiology, 2, 402–410.PubMedCrossRef

14.

Seifert, M., Schau, T., Moeller, V., Neuss, M., Meyhoefer, J., & Butter, C. (2010). Influence of pacing configurations, body mass index, and position of coronary sinus lead on frequency of phrenic nerve stimulation and pacing thresholds under cardiac resynchronization therapy. Europace, 12, 961–967.PubMedCrossRef

15.

Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., et al. (2009). Cardiac resynchronization therapy for the prevention of heart-failure events. New England Journal of Medicine, 361, 1329–1338.PubMedCrossRef

16.

Tang, A. S. L., Wells, G. A., Talajic, M., Arnold, M. O., Sheldon, R., Connolly, S., et al. (2010). Cardiac-resynchronization therapy for mild-to-moderate heart failure. New England Journal of Medicine, 363, 2385–2395.PubMedCrossRef

17.

Linde, C., Abraham, W. T., Gold, M. R., St John Sutton, M., Ghio, S., Daubert, C., et al. (2008). Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. Journal of the American College of Cardiology, 52, 1834–1843.PubMedCrossRef

18.

Cleland, J. G., Daubert, J. C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352, 1539–1549.PubMedCrossRef

19.

Knight, B. P., Desai, A., Coman, J., Faddis, M., & Yong, P. (2004). Long-term retention of cardiac resynchronization therapy. Journal of the American College of Cardiology, 44, 72–77.PubMedCrossRef

20.

Ailawadi, G., Lapar, D. J., Swenson, B. R., et al. (2010). Surgically placed left ventricular leads provide similar outcomes to percutaneous leads in patients with failed coronary sinus lead placement. Heart Rhythm, 7, 619–625.PubMedCentralPubMedCrossRef

21.

Merchant, F. M., Heist, E. K., McCarty, D., et al. (2010). Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm, 7, 639–644.PubMedCrossRef

22.

Lin, G., Anavekar, N. S., Webster, T. L., Rea, R. F., Hayes, D. L., & Brady, P. A. (2009). Long-term stability of endocardial left ventricular pacing leads placed via the coronary sinus. Pacing and Clinical Electrophysiology, 32, 1117–1122.PubMedCrossRef

Title: Single-center experience of a quadripolar pacing lead for cardiac resynchronization therapy
Authors: Antonello Vado
Endrj Menardi
Guido Rossetti
Gianpaolo Ballari
Mauro Feola
Marco Bobbio
Publication date: 01-03-2014
Publisher: Springer US
Published in: Journal of Interventional Cardiac Electrophysiology / Issue 2/2014
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI: https://doi.org/10.1007/s10840-013-9849-8

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Single-center experience of a quadripolar pacing lead for cardiac resynchronization therapy

Abstract

AIM

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

AIM

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2014

Unusual chest pain syndromes caused by implanted cardiac device leads: a case series

Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator

The prevalence and risk factors for atrioesophageal fistula after percutaneous radiofrequency catheter ablation for atrial fibrillation: the Canadian experience

Substrate modification by adding ablation of localized complex fractionated electrograms after stepwise linear ablation in persistent atrial fibrillation

Radiation tolerance of contemporary implantable cardioverter-defibrillators

A novel fluoroscopic method of measuring right-to-left interlead distance as a predictor of reverse left ventricular remodeling after cardiac resynchronization therapy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page